Clinical trial
Study of FX006 in Patients With Osteoarthritis of the Knee
NCT01487161 · Pacira Pharmaceuticals, Inc, Industry · Completed
Key facts
| NCT number | NCT01487161 |
|---|---|
| Title | Study of FX006 in Patients With Osteoarthritis of the Knee |
| Official title | A Double-Blind, Randomized, Parallel Group, Dose-Ranging Study Comparing FX006 to Commercially Available Triamcinolone Acetonide Injectable Suspension in Patients With Osteoarthritis of the Knee |
| Lead sponsor | Pacira Pharmaceuticals, Inc, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Osteoarthritis of the Knee |
| Intervention type | Drug |
| Interventions | FX006, TCA IR |
| Enrollment | 229 |
| Start date | Jun 1, 2012 |
| Primary completion | Apr 1, 2013 |
| Completion | Apr 1, 2013 |
| First posted | Dec 7, 2011 |
| Last update posted | Jan 24, 2024 |
| Countries | Australia, Canada, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: